申请人:Dart Neuroscience (Cayman) Ltd.
公开号:US10053467B2
公开(公告)日:2018-08-21
The invention provides a compound of formula I:
wherein A1, A2, A3, R1, X, Y, and B have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of monoamine oxidase B (MAO-B) enzyme function and are useful for improving cognitive function and for treating psychiatric disorders in animals.
本发明提供了一种式 I 的化合物:
其中A1、A2、A3、R1、X、Y和B具有本文所述的任何值,以及此类化合物的盐、包含此类化合物的组合物和包括施用此类化合物的治疗方法。这些化合物是单胺氧化酶 B(MAO-B)酶功能的抑制剂,可用于改善动物的认知功能和治疗精神疾病。